In mammals, lactation is a rich source of nutrients and antibodies for newborn animals.
Although the identity of endogenous AHR activators remains controversial, several exogenous chemicals have been shown to target AHR (Denison and Nagy, 2003) . In particular, we previously identified a 1,2,4-bis-aryloxadiazole, referred to as 1023, as a novel AHR agonist (Basham et al. , 2014; Basham et al., 2013 ).
An association between AHR activation and changes in milk production has been observed in animal studies. Specifically, pregnant mice exposed to TCDD in vivo produced lower levels of the milk proteins ~-casein ) and whey acidic protein (W AP) (Vorderstrasse et al., 2004) , and were unable to nutritionally support their offspring (Vorderstrasse et al., 2004) . Moreover, exposure of pregnant rats to TCDD led to severe defects in mammary gland differentiation and decreased pup size fo llowing lactation (Badesha et al., 1995; Fenton et al., 2002) , suggesting TCDD exposure impaired functional development of the mammary gland. Together with epidemiological studies in humans, these observations support a strong link between AHR activation and diminished milk production.
Despite these studies, the molecular mechanism through which AHR signaling blocks milk production remains unclear. Moreover, reciprocal transplant studies with AHR null mammary glands implicate both indirect, systemic effects and direct, cellular consequences of AHR signaling on alveolar differentiation (Lew et al., 2011 ) . Indirectly, TCDD disrupts endocrine function by altering estrogen-mediated signaling (Matthews and Gustafsson, 2006; Safe et al., 1998) . However, changes in circulating estrad iol, progesterone, or prolactin levels were not observed in pregnant mice after in vivo TCDD exposure (Vorderstrasse et al., 2004) , which suggests mammary tissue may respond directly to AHR agonists. Moreover, explant studies, where mammary glands were cultured ex vivo under hormonal stimulation with TCDD, showed decreased lobuloalveolar structures (Hushka et al., 1998) . Together, these studies suggest AHR signaling contributes to impaired lactogenesis by directly targeting mammary tissue.
Based on these initial observations, we hypothesized that the epithelium had a significant role in mediating the response to TCDD. Thus, we aimed to identify direct epithelial mechanisms through which AHR activation blocks P-casein production. Using in vitro models of mammary morphogenesis and differentiation, we show that both environmental toxicants (TCDD) and novel AHR agonists (1023) block lactogenesis directly in mammary epithelial cells.
Furthermore, we identify a new role for the aryl hydrocarbon receptor repressor (AHRR) in mediating this response. Our results support a model in which AHRR induction promotes formation of AHRR/ARNT heterodimers, which transcriptionally inhibit P-casein production.
MATERIALS AND METHODS
Mice. Mice were maintained following protocols reviewed and approved by the Univers ity of Utah Institutional Animal Care and Use Committee.
Isolation of primary ME Cs. Organoids from the fourth inguinal mammary gland were isolated from virgin (8-12-week-old) fema le mice and processed to single epithelial cells as previously described (Basham et al., 2013) .
Microarray data. Data previously generated (Basham et al., 2013) Chemical compounds. TCDD (Cambridge Isotopes Laboratories, Inc. , Andover, MA) was obtained as a DMSO stock solution and used at a final concentration of l 0 nM, which is within the range of exposures (0.1 nM -l 00 nM) previously reported to be environmentally and pharmacologically relevant (Birnbaum and DeVito, 1995) . 1023 was synthesized as previously described (Basham et al., 2013) and dissolved in OMSO at a stock concentration of 10 mM.
I 023 was used at a final concentration of l 0 µM. which was selected based on a previous dose response analysis in mammary epithelial cells (Basham et al. , 2013 ) RNA extraction, cDNA synthesis, and real-time PCR. RNA was isolated, converted to cDNA, and used for real-time PCR as previous ly described (Basham et al., 2013) . Primer sequences were as follows: j}-actin forward (5'-GGCTGTGCTGTCCCTGTATG-3'), j}-actin
a-casein
Plasmids and molecular cloning. Constructs expressing an shRNA against AHR or ARNT were previously generated (Basham et al. , 2013) using the pLcntilox5.0-GFP vector (Cai et al. , 2007) provided by Dr. James Bear (University of North Carolina, Chapel Hill, NC).
Lentiviral expression constructs were generated using the pEiZ plasmid (pHIV-Zsgreen, plasmid 18121, Addgene, Cambridge, MA) previously described (Welm et al., 2008) . For generation of pEiZ-HA-AHR, a mouse AHR expression plasmid (pACT AG-HA-AHR) provided by Dr. Oliver
Hankinson (University of California, Los Angeles, CA) was used to PCR amplify HA-AHR with the addition of Xbal restriction sites. The following primers were used for amplification:
(5'-TGCTTATCTAGAACCTCAACTCTGCACCTTGCTTAGGAAT-3'). The resulting PCR product was digested with Xbal and ligated into the same site in pEiZ. For generation of pEiZ-HA-AHRR, a mouse AHRR expression plasmid (pcDNA-mAhRR) (Karchner et al., 2002) provided by Dr. Mark Hahn (Woods Hole Oceanographic Institution, Woods Hole, MA) was used to PCR amplify AHRR with addition of an N-terminal HA tag and EcoRI restriction sites.
The following primers were used for amplification: forward ( Following site-directed mutagenesis, Topo-HAAHRRmutant was digested with EcoRI and the resulting fragment was ligated into pEiZ using the same site. For generation of pEiZ-HA-ARNT, an HA-tagged mouse ARNT expression plasmid (pACTAG-HA-ARNT) (Moffett et al., 1997) provided by Dr. Oliver Hankinson (University of California, Los Angeles, CA) was used to PCR amplify the HA-ARNT fragment with additional EcoRI restriction sites. The resulting PCR product was subcloncd into the pCR®2.1-TOPO® TA vector to create Topo-HA-ARNT, which was digested with EcoRl and ligated into the same site in pEiZ. The following plasmids for generating lentivirus have been previously described: pMDLg/pRRE (Dull et al. , 1998) , pRSV-Rev (Dull et al., 1998) , and pVSV-G (Clontech, Mountain View, CA). The identity of each plasmid was confirmed by sequencing.
Produ ction and titration of /entivirus. High titer lentivirus was produced, concentrated, and titrated as previously described (Basham et al., 2013) . 
RESULTS

AHR agonists inhibit expression of milk genes in mammaty epithelial cells-
To study the effect of AHR activation on lactation, we sought to recapitulate this process in vitro. Initially, we grew primary mammary epithelial cells (MECs) in our three-dimensional branching assay (Basham et al., 20 13) in the presence of I 023 , an AHR agonist, and performed microarray analysis to determine differentially expressed genes. Compared to vehicle treatment (DMSO), cells grown with I 0 µM I 023 showed down regulation of several genes important for milk production, including whey acidic protein and multiple casein genes (Table 1) . Given the lack of stromal components in this system (Basham et al., 2013; Welm et al. , 2008) , these results suggested AHR activation blocked milk genes through a direct mechanism in mammary epithelial cells.
To validate these results, we next utilized the HCJ l mammary epithelial cell line. HCl 1 cells were clonally derived from immortalized COMMA-1 D epithelial cells (Ball et al., 1988) , which were isolated from the mammary gland of midpregnant BALB/c mice (Danielson et al., 1984) . Importantly, HC 11 cells can be induced to differentiate with lactogenic hormones and produce milk proteins in culture (Ba1l et al. , 1988; Doppler et al., 1990) . first, we confirmed that l 023 and TCDD activated AHR in this system. Since AHR translocates to the nucleus following activation (Denison and Nagy, 2003; Heid et al., 2000; Pollenz et al., 1994) , we assessed AHR localization following treatment with 1023 or TCDD. Specifically, we stably expressed an HA-tagged AHR construct in HCI I cells and performed immunofluorescence for HA after 24 hours of drug treatment. We found that both 10 µM 1023 and 10 nM TCDD significantly increased the amount of nuclear AHR compared to DMSO (Fig. lA-B) .
Furthermore, we observed significant induction of the AHR response gene, cytochrome P450 l A I ( Cyp la/) (Whitlock, 1999) , in parental HC l l cells following 48 hours of compound treatment (Supplemental Fig. I.A) . Together, these experiments demonstrated 1023 and TCDD properly activated the AHR pathway in HCl l cells.
Next, we induced HC 11 cells with lactogenic hormones and tested the effect of AHR activation on f3-casein and a-casein expression. Using this assay, cells grown in the presence of IO µM l 023 or l 0 nM TCDD failed to produce the milk protein, P-casein, compared to vehicle treated cells (DMSO) (Fig. l C) . In agreement with our microarray data from primary MECs, mRNA expression of both /]-casein and a-casein were also inhibited ( Previously, we identified and validated AHR as the biological target of 1023 (Basham et al., 2013) . To confirm the observed inhibition of 13-cascin protein production was dependent on the AHR pathway, we used lentiviral constructs to generate stable HCI I cell lines expressing either a non-specific shRNA (Control) or an shRNA against AHR (shAHR # 1 and shAHR #2).
In cells with ~5 0% AHR knockdown (Supplemental Fig. IC) , we observed a partial rescue in 13-casein expression in the presence of AHR agonists (Fig. l D, Supplemental Fig. 1 D) . These results suggested l 023 and TCDD inhibited 13-casein production in mammary epithelial cells through AHR pathway activation.
The aryl hydrocarbon receptor repressor is sufficient to inhibit /]-casein -Given our data in both primary MECs and mammary HCl 1 cells, we hypothesized AHR activation blocked /J-
casein production through a transcriptional mechanism. Moreover, we became interested in a potential role for AHRR in mediating this process. As a direct target of activated AHR (Mimura et al., 1999) , AHRR is highly upregulated in primary MECs treated with I 023 (Basham et al., 2013) and has a known role as a transcriptional repressor. Specifically, AHRR shares high amino acid identity with the N-terminal portion of AHR, which contains both the basic helixloop-helix (bHLH) and Per-ARNT-Sim '·A" (PAS-A) domains (Mimura et al., 1999) . These regions of the AHR protein facilitate DNA binding and ARNT dimerization, which allows AHRR to form a heterodimer with ARNT and bind xenobiotic-responsive elements (XREs) in the promoter region of AHR target genes. Subsequent recruitment of a corepressor complex, which includes ANKRA2, HDAC4, and HDAC5, inhibits transcription of AHR target genes (Mimura et al., 1999; Oshima et al., 2007) .
To test the effect of AHRR on f3-casein expression, we first stably expressed a lentiviral HA-tagged AHRR construct in HCI I cells. We confirmed overexpression ( Fig. 2A ) and validated the construct by measuring a well-characterized AHR response gene, Cyp IA I.
Compared to control transduced cells, overexpression of AHRR decreased induction of Cyp/A I
after 48 hours of treatment with 10 µM 1023 (Fig. 28) . These results verified our tagged AHRR construct interacted with ARNT to functionally repress known target genes.
Next, we tested whether AHRR expression was sufficient to block P-casein production in the absence of AHR agonists. In HCI l cells induced with lactogenic hormones, and without exposure to AHR agonists, 13-casein production was repressed at both the mRNA (Fig. 2C ) and protein level ( AHRR contains a transcriptional repression domain within its C-terminal region, which consists of three conserved small ubiquitin-like modifier (SUMO)ylation sites at Lys-542, Lys-583, and Lys-660 . Previous studies demonstrated these lysine residues are modified by SUM0-1 to facilitate interaction between AHRR and its corepressor complex (Oshima et al., 2009) . To genetically test the requirement of this interaction for AI-IRR to inhibit P-casein production, we mutated all three lysine residues to arginine (HA-AHRRmutant). Previously, these mutations in AHRR have been shown to allow interaction between AHRR and ARNT, but prevent interaction between AHRR and its corepressor complex (Oshima et al., 2009) . Compared to HCl I cells overexpressing wild-type Al-IRR, overexpression of the SUMOylation mutanl signficantly rescued 13-casein production (Fig. 2E) , suggesting AHRR requires interaction with its corepressor complex to inhibit lactogenesis.
ARNT is required for fl-casein production in mammary epithelial ceffs-To elucidate the mechanism through which AHRR inhibits milk production, we examined the role of its major binding partner, ARNT, during normal lactation. Stable HC 11 cell lines expressing a nonspecific lentiviral shRNA (Control) or a lentiviral shRNA against ARNT (shA RNT # 1 or shARNT #2) were generated ( Fig. 3A-B ). Following induction with lactogenic hormones, knockdown of ARNT inhibited P-casein expression at both the mRNA (Fig. 3C ) and protein level (Fig. 3D) , and expression of a-casein mRNA (data not shown). As loss of AHR in the absence of any chemical agonists had no effect on P-cascin production in HC 11 cells (Fig. lD) , these results implicated an independent role for ARNT during milk production.
Overexpression of ARNT rescues fl-casein production in the presence of AHR agonists-
Based on our results, we hypothesized ARNT participated in a transcriptionally active complex to promote expression of milk genes, such as P-casein, during lactogcnesis. Furthermore, since ARNT was required for lactogenesis, we speculated AHRR might inhibit milk production through competitive interactions with ARNT. To test this hypothesis, we ovcrcxpressed ARNT prior to treatment with AHR agonists and measured P-casein levels to assess milk production.
We reasoned overexpression of ARNT would promote transcriptionally active complexes and restore P-casein levels in the presence of AHR agonists. In HC I I cells stab ly overexpressing a lentiviral HA-ARNT construct (Fig. 4A ), we found P-casein expression partially restored in the presence of both I 0 µM 1023 and 10 nM TCDD compared to control cells ( fig. 48) . These results support a model in which AHRR blocks production of P-casein by acting as a transcriptional reprcssor to inhibit ARNT signaling.
DISCUSS ION
Using an epithelial-based model of mammary lactation, we demonstrate AHR agonists directly block P-casein expression. Specifically, we showed AHRR, a robust downstream target of AHR signaling, was sufficient to inhibit the production of P-casein. Although well studied in the context of AHR activation, AHRR is also induced by other toxic insults. In particular, recent studies showed cigarette smoking, including secondhand exposure, caused significant demethylation and increased expression of AHRR (Philibert et al., 2012; Shenker et al. , 2013) .
As women who smoke have consistently been shown to produce significantly less milk volume (Hopkinson et al., 1992; Vio et al., 1991) and breastfeed for a shorter duration (Andersen and Schioler, 1982; Hakansson and Carlsson, 1992; Schulte-Hobein et al., l 992; Vio, Salazar and Infante, 199 L; Whichelow, 1979) , our results provide a potential molecular mechanism through which this toxicity occurs.
Following induction, AHRR forms a heterodimer complex with ARNT (Evans et al. , 2008) . As loss of ARNT significantly blocked P-casein production in mammary epithelial cells, our results implicate an important role for ARNT during lactation. These observations are consistent with the phenotype observed in conditional ARNT knockout mice, where ARNT deletion using the MMTV-Cre transgene resulted in impaired mammary function (Le Provost et al. , 2002) . Specifically, loss of ARNT led to incomplete alveolar development, smaller litter sizes, and 60% of dams that could not support their pups.
However, inactivation of ARNT using W AP-Cre resulted in normal mammary differentiation during pregnancy (Le Provost et al., 2002) . Furthermore, transplantation of ARNT null mammary epithelium generated using MMTV-Cre into wild-type recipients normalized alveolar development (Le Provost et al. , 2002) . Although inconsistent with initial studies and our current findings, these incongruent results may be explained by differences in methodology. Specifically, W AP-Cre reduced ARNT levels in 80% of the mammary epithelium (Le Provost et al. , 2002; Walton et al., 2001) , resulting in residual ARNT expression that may facilitate normal development. Jn reciprocal transplant studies, the high selective pressure of transplantation may have induced compensation from other ARNT family members, including ARNT2 . Expressed in the mammary gland (Martinez et al. , 2008) , ARNT2 is known to form functional complexes with AHR (Hirose et al., 1996) and may be capable of contributing to mammary development. Further in vivo studies will be required to explain these differences.
Our experiments with AHRR and ARNT suggest a model in which ARNT promotes milk production under lactogenic conditions (Fig. 5) . As a bHLH-PAS family member, ARNT requires dimerization to form a functional transcription complex. Although ARNT is known to interact with mu ltiple proteins, we hypothesize that hypoxia inducible factor-1 a (HTFI a) or single-minded 2 (SIM2) interact with ARNT to promote lactation. In previous studies, conditional knockout of ARNT prevented induction of known HIF I a target genes (Tomita et al. , 2000) , suggesting ARNT is critical for HIF I a signal transduction. Additionally, deletion of HIF la in the mammary epithelium resulted in severe differentiation defects and failed lactation (Seagroves et al. , 2003) . Previous studies with SIM2 also support its potential role in cooperating with ARNT to regulate lactation. With SIM2 overexpression, precocious production of P-casein and WAP occurred in vitro and in vivo, and chromatin immunoprecipitation (ChTP) experiments showed S1M2 associated with the P-casein promoter. Conversely, loss of SIM2 inhibited milk production (Wellberg et al., 20 I 0) . Taken together, these experiments strongly implicate a role for HIFla or STM2 in promoting ARNT-mediated lactogenesis.
In response to toxic stimuli, our data suggest that AHRR/ARNT hcterodimers form and arc sufficient to block lactation. One potential mechanism of AHRR repression under these conditions is ARNT sequestration. Competition for a limited pool of ARNT has been observed previously, where ARNT availability regulated AHR signaling through HIFla (Gradin et al., 1996) and SIMI (Probst et al. , 1997; Woods and Whitelaw, 2002) . However, our experiments using an AHRR repression mutant that could bind ARNT, but not recruit a corepressor complex, suggest this is not the dominant mechanism. Rather, our results favor a model in whkh AHRR SUMOylation and subsequent recruitment of a corepressor complex that includes ANKRA2, HDAC4, and HD.ACS blocks transcription of genes important for milk production. further experiments will be needed to determine whether activating ARNT complexes and repressive AHRR/ARNT heterodimers bind the same DNA response elements. Additionally, these studies will help determine whether ARNT-mediated complexes bind directly in the promoter region of milk target genes or whether they control activity of an intermediate factor(s). We have not identified AHR consensus elements within the mouse or human P-casein promoters, and since several milk genes are affected by AHR signaling it is possible global rather than direct pathways attenuate lactation. Further studies will be necessary to determine the targets of AHR signaling that modulate lactogenesis.
Our data demonstrate AHR signaling directly disrupts milk protein production in isolated mammary epithelial cells. Since industrial waste is one of the main sources of TCDD and other related polyhalogenated aromatic hydrocarbons, human exposure to these toxicants is highest in industrialized countries (Schecter et al., 2006a) . However, acute exposure has occurred m several distinct populations worldwide, including exposure to Agent Orange herbicide m
Vietnam (Schecter et al. , 2006b) , indigenous Canadian Inuit populations who consume contaminated marine species (Ayotte et al., 1996) , and people living in Seveso, Italy during the 1976 industrial explosion (Warner et al., 2002) , among others. Given the prevalence of these 
